SK
Sanjay Kulkarni
Director Manufacturing at Bilthoven Biologicals
View Sanjay's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Director Manufacturing
Feb 2024 - Present · 10 months
Additional Director
Jan 2015 - Feb 2024 · 9 years and 1 months
Lead, Supply Chain Transformation,South Asia
Apr 2014 - Jan 2015 · 9 months
Company Details
201-500 Employees
About Bilthoven Biologicals Bilthoven Biologicals is a biopharmaceutical company which produces Inactivated Polio Vaccines (IPV), Tetanus Vaccines, Diphtheria-Tetanus-Polio Vaccines (DT-PV) and Bacillus Calmette-Guérin (BCG) for the treatment of bladder cancer. We deliver our vaccines to UNICEF, with which we support the World Health Organisation (WHO) to eradicate polio. Bilthoven Biologicals has been part of the Cyrus Poonawalla Group since 2012, the world’s largest vaccine producer and employs more than 500 employees. www.bbio.nl | www.werkenbijbbio.nl | https://www.bbio.nl/en/what-we-produce/report-side-effects/ Over Bilthoven Biologicals Bilthoven Biologicals is een biofarmaceutisch bedrijf dat geïnactiveerde polio vaccins (IPV), Tetanus vaccins, Difterie-Tetanus-Polio vaccins (DT-IPV) produceert en Bacillus Calmette-Guérin (BCG) voor de behandeling van blaaskanker. Wij leveren onze vaccins aan UNICEF, waarmee wij de Wereldgezondheidsorganisatie (WHO) ondersteunen bij het uitroeien van polio. Bilthoven Biologicals is sinds 2012 onderdeel van de Cyrus Poonawalla Group, de grootste vaccinproducent ter wereld en heeft ruim 500 medewerkers. www.bbio.nl | www.werkenbijbbio.nl | https://www.bbio.nl/wat-wij-maken/bijwerkingen-melden/
Year Founded
2012
Social Media
LinkedinFacebook
Industry
Pharmaceutical Manufacturing
HQ Location
Antonie van Leeuwenhoeklaan 11 Bilthoven, Utrecht 3721 MA, NL
Keywords
--
Discover More About Cleveland Clinic

Find verified contacts of Sanjay Kulkarni in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.